Altered lipid profile in patients with COVID-19 infection
暂无分享,去创建一个
[1] Jiajia Xie,et al. Biochemical characterization of SARS-CoV-2 nucleocapsid protein , 2020, Biochemical and Biophysical Research Communications.
[2] G. Natalini,et al. Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? , 2020, Acta bio-medica : Atenei Parmensis.
[3] Guiqing He,et al. Low Serum Cholesterol Level Among Patients with COVID-19 Infection in Wenzhou, China , 2020 .
[4] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[5] Hongzhou Lu,et al. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle , 2020, Journal of medical virology.
[6] E. Latz,et al. High-Density Lipoproteins Decrease Proinflammatory Activity and Modulate the Innate Immune Response. , 2019, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[7] Mingzhou Chen,et al. Virion-Associated Cholesterol Regulates the Infection of Human Parainfluenza Virus Type 3 , 2019, Viruses.
[8] Y. Li,et al. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection , 2017, Scientific Reports.
[9] O. Yang,et al. Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection , 2016, AIDS.
[10] A. Remaley,et al. High‐density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation , 2016, Immunology.
[11] N. Mehta,et al. Lipid Abnormalities and Inflammation in HIV Inflection , 2016, Current HIV/AIDS Reports.
[12] M. Lederman,et al. Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation , 2015, Journal of acquired immune deficiency syndromes.
[13] Christian Drosten,et al. Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group , 2013, Journal of Virology.
[14] H. Kaji. High-Density Lipoproteins and the Immune System , 2013, Journal of lipids.
[15] O. Yang,et al. A biochemical fluorometric method for assessing the oxidative properties of HDL[S] , 2011, Journal of Lipid Research.
[16] D. Sviridov,et al. Neutrophil Activation Is Attenuated by High-Density Lipoprotein and Apolipoprotein A-I in In Vitro and In Vivo Models of Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[17] N. Heaton,et al. Multifaceted roles for lipids in viral infection , 2011, Trends in Microbiology.
[18] S. Reddy,et al. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms , 2011, Nature Reviews Cardiology.
[19] C. Schwegmann-Wessels,et al. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2 , 2008, Virology.
[20] J. Tam,et al. Lipid rafts are involved in SARS-CoV entry into Vero E6 cells , 2008, Biochemical and Biophysical Research Communications.
[21] K. Ikuta,et al. Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle , 2006, Microbes and Infection.
[22] G. Franceschini,et al. Endothelial Protection by High-Density Lipoproteins: From Bench to Bedside , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[23] S. Cole,et al. Impact of HIV infection and HAART on serum lipids in men. , 2003, JAMA.
[24] J. A. Comer,et al. A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[25] J. Gamble,et al. Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. , 2000, Journal of lipid research.
[26] Jeani Chang,et al. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. , 1993, The American journal of medicine.
[27] K. Feingold,et al. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. , 1992, The Journal of clinical endocrinology and metabolism.